Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.50
Bid: 31.00
Ask: 32.00
Change: 1.00 (3.28%)
Spread: 1.00 (3.226%)
Open: 30.50
High: 31.50
Low: 30.50
Prev. Close: 30.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Pennant Court

3 Aug 2022 07:00

RNS Number : 7414U
Pennant International Group PLC
03 August 2022
 

 

FOR IMMEDIATE RELEASE

3 August 2022 

PENNANT INTERNATIONAL GROUP PLC

Sale of Pennant Court

 

 

Pennant International Group plc (AIM:PEN) ("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, announces that it has exchanged contracts for the sale of its facility known as Pennant Court.

 

With the Group's increasing software focus and reduced reliance on resource-intensive hardware engineering activities, earlier this year the Board commissioned a comprehensive review of the Group's UK facilities. Recognising a reduced requirement for space at its Cheltenham operating sites, the Board decided to market for sale the Group's former Cheltenham head office, Pennant Court.

 

The Pennant Court site comprises a single unit subdivided between offices and a warehouse, totalling over 19,000 square feet of floor space in aggregate.

 

An offer for Pennant Court was accepted in May this year and contracts have now been exchanged for the sale of the freehold title. The vendor is Pennant International Limited and the buyer is Pripco Limited. Completion is scheduled for 19 August 2022. Pennant has not entered into any leaseback arrangement in relation to any part of the property and will vacate the site entirely upon completion.

 

The sale price is £2.1 million (plus VAT), which will be payable in full, in cash on completion. After transaction expenses, the sale is expected to realise a profit of £0.2 million. The Board considers that the sale price fairly reflects Pennant Court's market value.

 

The sale proceeds will be used to reduce the Group's overdraft, which currently stands at circa £4.2 million overdrawn (against a temporary limit of £5 million) such that immediately after the sale, the Group expects to be around £2.1 million overdrawn against an updated limit of £3 million (adjusted for the release of the asset from the bank's security package).

 

Following the sale, the Group expects to realise savings of circa £0.2 million per annum in respect of running costs, business rates and other expenses related to Pennant Court.

As a result of the aforementioned facilities review, the Group will also terminate its office lease in Stevenage this month and is in the early stages of negotiations to surrender another leased premises. The Group will continue to have sufficient facilities to service its order book and pipeline opportunities with 30,000 square feet of retained facilities in Cheltenham alone.

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director 

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEASPDELNAEEA
Date   Source Headline
1st Nov 20211:23 pmRNSHolding in Company
28th Oct 20212:26 pmRNSHolding in Company
12th Oct 20212:44 pmRNSGrant of Option
30th Sep 20215:02 pmRNSHolding in Company
28th Sep 20214:31 pmRNSHolding in Company
27th Sep 20215:02 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSDirector/PDMR Share Purchases
22nd Sep 20217:00 amRNS2021 Interim Results
7th Sep 20212:44 pmRNSHolding in Company
31st Aug 20212:05 pmRNSSecond Price Monitoring Extn
31st Aug 20212:00 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSTrading Update & Notice of Interim Results
2nd Jun 20214:48 pmRNSResults of AGM & Appointment of new Chairman
27th May 20217:00 amRNSAGM Update
29th Apr 20213:31 pmRNSNotice of AGM
28th Apr 20212:05 pmRNSSecond Price Monitoring Extn
28th Apr 20212:00 pmRNSPrice Monitoring Extension
28th Apr 20217:00 amRNS2020 Final Results
19th Apr 20217:00 amRNSRescheduling of 2020 Final Results
1st Apr 20214:46 pmRNSIssue of Equity & Director Dealings
10th Mar 20217:00 amRNSNotice of Final Results
9th Mar 20217:00 amRNSHoldings in Company
9th Mar 20217:00 amRNSHoldings in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
5th Oct 202011:02 amRNSHolding(s) in Company
5th Oct 202011:01 amRNSHolding(s) in Company
5th Oct 202011:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNS2020 Interim Results
11th Sep 20207:00 amRNSHolding(s) in Company
11th Sep 20207:00 amRNSHolding(s) in Company
8th Sep 20207:00 amRNSHoldings in Company
13th Aug 20207:00 amRNSTrading Update & Notice of Interim Results
29th Jul 20203:47 pmRNSDirector/PDMR Shareholding
17th Jul 20207:00 amRNSNew Contract & Notice of Half-Year Trading Update
22nd May 20207:00 amRNSBusiness Update
15th May 202012:00 pmRNSResult of AGM
20th Apr 20201:58 pmRNSIssue of Equity and Director Dealing
20th Apr 20207:00 amRNS2019 Preliminary Results
25th Mar 20207:00 amRNSCovid-19 Update
16th Mar 202012:51 pmRNSNotice of Results
10th Mar 202012:00 pmRNSContract Update
3rd Mar 202010:00 amRNSCompletion of Australian Acquisition
19th Feb 20207:00 amRNSStatement of Intent for Prospective £5m Contract
7th Feb 202011:08 amRNSHolding(s) in Company
3rd Feb 20207:00 amRNSContract Wins
3rd Feb 20207:00 amRNSTrading Update
22nd Jan 20204:58 pmRNSHoldings in Company
21st Jan 20207:00 amRNS£3.44m Australian Acquisition
22nd Nov 20197:00 amRNSBoard Re-organisation & Directorate Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.